Developing affordable technologies for cervical cancer prevention and diagnosis in women with HIV

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

NIH-funded research University of Tx Md Anderson Can Ctr · NIH-10895285

The AVANÇO Research Consortium is working to find better and affordable ways to screen and treat cervical cancer for women living with HIV in low- and middle-income countries, so they can have healthier lives.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-10895285 on NIH RePORTER

What this research studies

The AVANÇO Research Consortium aims to create sustainable research programs that focus on cervical cancer screening, diagnosis, and treatment specifically for women living with HIV in low- and middle-income countries. This collaborative effort involves institutions from the US, Mozambique, and Brazil, leveraging expertise in various fields such as bioengineering and epidemiology. The research will explore innovative, low-cost methods to improve cervical cancer outcomes for this vulnerable population, addressing a significant health disparity. By establishing a robust research infrastructure, the project seeks to enhance the understanding and management of HIV-associated malignancies.

Who could benefit from this research

Good fit: Ideal candidates for this research are women living with HIV, particularly those in low- and middle-income countries.

Not a fit: Patients who are not living with HIV or those who do not have access to the targeted regions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved cervical cancer prevention and treatment options for women living with HIV, ultimately saving lives.

How similar studies have performed: Previous research has shown success in developing low-cost health technologies for underserved populations, indicating potential for this approach.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions AIDS Associated Opportunistic InfectionAIDS associated cancerAIDS opportunistic infectionsAIDS related cancerAIDS-Related Opportunistic Infections
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.